McMaster University

Medical Sciences
Graduate Program

Scope of Search

 

Murray Potter

Murray Potter

 

MD

Professor and Chair,

Department of Pathology and Molecular Medicine, Division of Clinical Pathology

Associate Member, Department of Pediatrics, Division Head - Genetics and Metabolics

Research Interests

The major focus of my research is on inborn errors of metabolism/biochemical genetics. This encompasses clinical research in the treatment of these disorders and the development of diagnostic tests, particularly the development and clinical validation of mass-spectrometry based assays.

 

I spend most of my clinical time in the area of biochemical genetics, either running Metabolic Genetic clinics at McMaster Children's Hospital, or directing the Biochemical Genetics Laboratory at the Hamilton Regional Laboratory Medicine Program. I am also head of the regional newborn screening follow-up program and member of the Newborn Screening Ontario Advisory Council.

Academic Interests

I primarily teach post-graduate trainees in laboratory medicine and pediatrics residency and fellowship programs. I am also an active member of the national governing bodies for medical biochemistry (Royal College of Physicians and Surgeons of Canada) and biochemical genetics (Canadian College of Medical Geneticists).

Contact

McMaster University
Health Sciences Centre
Room 2N16

telephone: (905) 521-2100 ext. 76332
email: mpotter@mcmaster.ca

Assistant: Jane Goad

 

Program Area

Cancer & Genetics

 

Research Areas

Analytical chemistry, Mass Spectrometry, Chromatography, Biochemical Genetics, Inborn Errors of Metabolism

Selected Publications

  • Vomiting and seizure following circumcision in an infant. Fleming L, Oliver J, Potter M, Kam AJ. Paediatr Child Health. 2019 Jun;24(3):146-147. doi: 10.1093/pch/pxx202. Epub 2018 Jul 9. PMID: 31110452.
  • Health services use among children diagnosed with medium-chairn acyl-CoA dehydrogenase deficiency through newborn screening. Karaceper MD, Khangura SD, Wilson K, Coyle D, Brownell M, Davies C, Dodds L, Feigenbaum A, Fell DB, Grosse SD, Guttmann A, Hawken S, Hayeems RZ, Kronick JB, Laberge AM, Little J, Mhanni A, Mitchell JJ, Nakhla M, Potter M, Prasad C, Rockman-Greenberg C, Sparkes R, Stockler S, Ueda K, Vallance H, Wilson BJ, Chakraborty P, Potter BK; Canadian Inherited Metabolic Diseases Research Network (CIMDRN). Orphanet J Rare Dis. 2019 Mar 22;14(1):70.  doi: 10.1186/s13023-019-1001-0. PMID: 30902101.
  • Severe cyctic degeneration and intractable seizures in a newborn with molybdenum cofactor deficiency type B. Hannah-Shmouni F, MacNeil L, Potter M, Jobling R, Yoon G, Laughlin S, Blaser S, Inbar-Feigenberg M. Mol Genet Metab Rep. 2018 Dec 20;18:11-13. doi: 10.1016/j.ymgmr.2018.12.003. eCollection 2019 Mar. PMID: 30619713.
  • The creation of a national coalition to target adolescent idiopathic scoliosis: a meeting report. Cioana M, Peterson D, Missiuna P, El-Hawary R, Carey T, Potter MA, Banfield L, Thabane L, Samaan MC. Adolesc Health Med Ther. 2019;10:15-19. doi: 10.2147/AHMT.S199489. eCollection 2019. PubMed PMID: 30863194; PubMed Central PMCID: PMC6390871.
  • Approach to the interpretation of unexpected laboratory results arising in the care of patients with inborn errors of metabolism (IEM). Mattman A, Potter M.  Rev Ednocr Metab Disord. 2018 Mar;19(1):5-12. doi: 10.1007/s11154-018-9453-4. Review. PMID: 30032338.
  • Biotinidase dficiency: Spectrum of molecular, enzymatic and clinical information from newborn screening Ontario, Canada (2007-2014).  Gannavarapu S, Prasad C, DiRaimo J, Napier M, Goobie S. Potter M, Chakraborty P, Karaceper M, Munoz T, Schulze A, Mackenzie J, Li L, Geraghty MT, Al-Dirbashi OY, Rupar CA. Mol Genet Metab. 2015 Nov; 116)3):146-51. doi: 10.1016/j.ymgme.2015.010.
  • The relationship between trimethylamine-N-oxide and prevalent cardiovascular disease in a multi-ethnic population living in Canada.  Mente A, Chalcraft K, Ak H, Davis AD, Lonn E, Miller R, Potter MA, Yusuf S, Anand SS, McQueen MJ. Canadian Journal of Cardiology 2015 Sep;31(9):1189-94. doi: 10.1016/j.cjca.2015.06.016.  Epub 2015 Jun 25.
  • Beta-Alanine Supplementation Does Not Augment the Skeletal Muscle Adaptive Response to Six Weeks of Sprint Interval Training. Cochran AJ, Percival ME, Thompson S, Gillen JB, MacInnis MJ, Potter MA, Tarnopolsky MA, Gibala MJ. Int J Sport Nutr Exerc Metab. 2015 Dec;25(6):541-9. doi: 10.1123/ijsnem.2015-0046. Epub 2015 May 22.
  • Metabolic clinic atlas: Organization of care for children with inherited metabolic disease in Canada. Lamoureux MF, Tingley K, Kronick JB, Potter BK, Chan AKJ, Coyle D, Dodds L, Dyack S, Feigenbaum A, Geraghty MT, Gillis J, Rockman-Greenberg C, Khan A, Little J, MacKenzie J, Maranda B, Mhanni A, Mitchell G, Laberge AM, Potter M, Prasad C, Siriwardena K, Speechley KN, Stockler S, Trakadis Y, Turner L, van Karnebeek C, Wilson K, Chakraborty P, on behalf of the Canadian Inherited Metabolic Diseases Research Network. JIMD Reports 2015;21:15-22. doi: 10.1007/8904_2014_347. Epub 2015 Feb 26.